⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6509441 | 0.73 | TDP1 (0.37) | — | |
| (Phenylsulfinyl)Benzene SCHEMBL43199 | 0.73 | TDP1 (0.37) | — | |
| (Phenylsulfinyl)Benzene SCHEMBL28806865 | 0.73 | LMNA (0.33) | — | |
| Fluoride Ion SCHEMBL946294 | 0.71 | ALDH1A1 (0.35) | — | |
| (Phenylsulfinyl)Benzene SCHEMBL11889252 | 0.71 | TDP1 (0.35) | — | |
| SCHEMBL12336893 | 0.71 | TDP1 (0.35) | — | |
| (Phenylsulfinyl)Benzene SCHEMBL29381213 | 0.71 | TDP1 (0.35) | — | |
| SCHEMBL3834350 | 0.71 | — | — | |
| (Phenylsulfinyl)Benzene SCHEMBL11455732 | 0.71 | TDP1 (0.35) | — | |
| (Phenylsulfinyl)Benzene SCHEMBL30226308 | 0.71 | TDP1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132782-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. | 2023-05-04 | — | — | US | claimed |
| EP-4121040-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | Global Biolife Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| CN-115397410-A | Methods and compositions for treating, preventing, or limiting the occurrence of viral infections | 环球生物生命有限公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2021188520-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. (US) | 2021-09-23 | — | — | WO | claimed |
| US-8034838-B2 | Composition and method for the treatment of neurological disorders | GLOBAL BIOLIFE, INC. | 2011-10-11 | — | — | US | claimed |
| US-20090298932-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | GLOBAL BIOLIFE, INC. | 2009-12-03 | — | — | US | claimed |
| CN-118166397-A | Preparation of polymer carbon fiber photo-anode and application of polymer carbon fiber photo-anode in photo-decomposition of water | 福州大学 | 2024-06-11 | — | — | CN | disclosed |
| US-20230132782-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. | 2023-05-04 | — | — | US | disclosed |
| WO-2023014979-A1 | CONJUGATES COMPRISING COVALENT BINDERS FOR TARGETING INTRACELLULAR KRAS G12C PROTEINS | RAYZEBIO, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-4121040-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | Global Biolife Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| CN-115397410-A | Methods and compositions for treating, preventing, or limiting the occurrence of viral infections | 环球生物生命有限公司 | 2022-11-25 | — | — | CN | disclosed |
| WO-2021188520-A1 | METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE OCCURRENCE OF VIRAL INFECTION | GLOBAL BIOLIFE INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| CN-109475757-A | The phenolic compound that electrophilic for treating inflammation related disease and disorder enhances | 环球生物生命有限公司 | 2019-03-15 | — | — | CN | disclosed |
| US-8034838-B2 | Composition and method for the treatment of neurological disorders | GLOBAL BIOLIFE, INC. | 2011-10-11 | — | — | US | disclosed |
| EP-2308865-A1 | Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping, and method of optically forming three-dimensional shape | Adeka Corporation (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20090298932-A1 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | GLOBAL BIOLIFE, INC. | 2009-12-03 | — | — | US | disclosed |
| EP-1411942-A4 | SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS | SYNAPTIC PHARMA CORP (US) | 2005-01-26 | — | — | EP | disclosed |
| EP-1411942-A1 | SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS | Synaptic Pharmaceutical Corporation (US) | 2004-04-28 | — | — | EP | disclosed |
| WO-2003004027-A1 | SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2003-01-16 | — | — | WO | disclosed |
| US-4327100-A | USEFUL AS HYPERTENSIVE AND CARDIOTONIC AGENTS | BOEHRINGER INGELHEIM GMBH (DE) | 1982-04-27 | — | — | US | disclosed |